Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2012

01-07-2012 | Original Article

Impedance pH Confirms the Relationship Between GERD and BMI

Authors: Nasser Hajar, Donald O. Castell, Hassan Ghomrawi, Richard Rackett, Amine Hila

Published in: Digestive Diseases and Sciences | Issue 7/2012

Login to get access

Abstract

Background

During the last 20 years the prevalence of both gastroesophageal reflux disease (GERD) and obesity has been increasing in the United States. The pathophysiology of GERD is multifactorial and its relationship with obesity is still not well understood.

Aim

To evaluate the association between BMI and GERD as detected by multichannel intraluminal impedance-pH (MII-pH) monitoring.

Methods

Retrospective review of 122 consecutive MII-pH studies of adult patients while on PPI therapy. Patients were divided into normal (BMI < 25), overweight (BMI ≥ 25 and <30) and obese (BMI ≥ 30). Reflux episodes were classified as acid reflux (AR), nonacid reflux (NAR), and total number of reflux episodes, as detected by MII-pH. We evaluated the symptoms associated with reflux by using the symptom index (SI). We also assessed the number of reflux episodes during recumbency and compared them in the different BMI groups.

Results

The total number of reflux episodes and NAR episodes increased significantly as BMI increased. There was no significant difference between groups in AR. Similarly, during recumbency, total number of reflux episodes increased significantly when BMI increased. For symptoms associated with reflux, SI was more likely to be positive in the obese group.

Conclusions

This study shows a clear association between increased reflux as detected by MII-pH and higher BMI. Obesity not only increases the likelihood of reflux events, as shown in previous studies, but also makes it more likely that symptoms reported during MII-pH studies are actually due to MII detected reflux.
Literature
1.
go back to reference Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.PubMedCrossRef Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.PubMedCrossRef
2.
go back to reference Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.PubMedCrossRef
3.
go back to reference Ogden CL, Carroll MD, McDowell, et al. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS Data Brief. 2007;1:1–8. Ogden CL, Carroll MD, McDowell, et al. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS Data Brief. 2007;1:1–8.
4.
go back to reference Blumberg SJ, Luke JV, Davidson G, et al. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Report. 2009;11:16. Blumberg SJ, Luke JV, Davidson G, et al. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Report. 2009;11:16.
5.
go back to reference El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.PubMedCrossRef El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.PubMedCrossRef
6.
go back to reference Lambert R. In search of reliability in the description of gastroesophageal reflux disease (GERD). Esophagus. 2008;5:5–9.CrossRef Lambert R. In search of reliability in the description of gastroesophageal reflux disease (GERD). Esophagus. 2008;5:5–9.CrossRef
7.
go back to reference El Serag HB. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.PubMedCrossRef El Serag HB. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.PubMedCrossRef
8.
go back to reference Crowell MD, Bradley A, Hansel S, et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol. 2009;104:553–559.PubMedCrossRef Crowell MD, Bradley A, Hansel S, et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol. 2009;104:553–559.PubMedCrossRef
9.
go back to reference Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13:1440–1447.PubMedCrossRef Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13:1440–1447.PubMedCrossRef
10.
go back to reference Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.PubMedCrossRef Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.PubMedCrossRef
11.
go back to reference Hirano I, Richter JE, et al. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.PubMedCrossRef Hirano I, Richter JE, et al. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.PubMedCrossRef
12.
go back to reference National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6:51S–209S. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6:51S–209S.
13.
go back to reference Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–361.PubMed Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–361.PubMed
14.
go back to reference Singh S, Richter JE, Bradley LA, et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38:1402–1408.PubMedCrossRef Singh S, Richter JE, Bradley LA, et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38:1402–1408.PubMedCrossRef
15.
go back to reference Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.PubMedCrossRef Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.PubMedCrossRef
16.
go back to reference Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996;91:1532–1538.PubMed Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996;91:1532–1538.PubMed
17.
go back to reference World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO convention, Geneva, 1999. World Health Organ Tech Rep Ser. 2000;894:1–253. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO convention, Geneva, 1999. World Health Organ Tech Rep Ser. 2000;894:1–253.
18.
go back to reference Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol. 2006;101:460–463.PubMedCrossRef Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol. 2006;101:460–463.PubMedCrossRef
19.
go back to reference Pandolfino J. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–1357. Pandolfino J. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–1357.
20.
go back to reference Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–889.PubMedCrossRef Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–889.PubMedCrossRef
21.
go back to reference Pandolfino JE, El Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649.PubMedCrossRef Pandolfino JE, El Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649.PubMedCrossRef
Metadata
Title
Impedance pH Confirms the Relationship Between GERD and BMI
Authors
Nasser Hajar
Donald O. Castell
Hassan Ghomrawi
Richard Rackett
Amine Hila
Publication date
01-07-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2131-6

Other articles of this Issue 7/2012

Digestive Diseases and Sciences 7/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.